Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01638533
Title Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lymphoma

Advanced Solid Tumor

chronic lymphocytic leukemia

Therapies

Romidepsin

Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
National Cancer Institute Developmental Therapeutics Clinic Bethesda Maryland 20892 United States Details
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033-0850 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
University Health Network-Princess Margaret Hospital Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field